Gregory Driessens

Company: iTeos Therapeutics
Job title: Program Leader
Seminars:
Engagement of FcγR by a-TIGIT mAbs: Does It Matter & Why? 3:00 pm
• Comparing differentiated mechanisms of action of Fc-live and Fc-dead a-TIGIT drugs • How do Fc-live and Fc-dead a-TIGIT compare in preclinical setting? • How do Fc-live and Fc-dead a-TIGIT compare in patients?Read more
day: Day Two